Biotech Values

[pmony5]

TTNP DD post $1.38 pps 103 Million dollar market cap. has currently 22 million in cash with approx 64 million due to TTNP upon FDA approval & warrant conversions = 86 million dollars less cash burn through April which is very low right now. TTNP has been around for 20 years & started out as a listed company but share price fell well below listing standards & went to the BB always with completed filings & CEO stated 2013 up listing a priority. Titan has a unique delivery system implantable drug delivery with a continuous 6 month dosage in 1 match stick sized implant in the upper arm. Think about the compliance improvement for not just opioid addiction but chronic pain, Parkinson's, Alzheimer's etc all drugs where compliance is absolutely necessary but typically does not happen. I will post some good articles & Analyst information too start with.

Analyst Jason Napodano, CFA

http://bionapcfa.blogspot.com/search/label/Titan%20Pharma

priority review press release

http://finance.yahoo.com/news/probuphine-r-receives-fda-priority-120000404.html

Titan's partner deal press release note the 75 Million dollars pledged by partner for commercial roll out of Probuphine.

http://finance.yahoo.com/news/titan-pharmaceuticals-licenses-exclusive-probuphine-120000246.html

Pre partner analyst article naming TTNP & reasons for buying with $4.00 target.

http://seekingalpha.com/article/1064451-do-you-have-the-guts-to-take-on-cutting-edge-biotech-like-this-vc?source=yahoo

A Wall street journal article on opioid addiction & Titans treatment option

http://online.wsj.com/article/SB10001424052702303684004577506983158087406.html?KEYWORDS=titan#articleTabs%3Darticle